Ads
related to: pad disease- ASCVD Patients
Find How To Identify Your Patients
Risk Status. Learn More.
- LDL-C Testing Options
See LDL-C Testing Recommendations.
Learn More About Testing Options.
- Managing Patient LDL-C
Discover Nine Important Modifiable
Heart Attack Risk Factors.
- For Your ASCVD Patients
Identify Your Patients' Risk Status
Based on Risk Factors. Learn More.
- LDL-C Testing Frequency
Find Information On LDL-C Testing
For You And Your Patients.
- HCP ASCVD Resources
Access Resources For Your Patients
Living In The Red.
- ASCVD Patients
Search results
Study Reveals This 1 Exercise Can Reduce Arthritis And Knee Pain
HuffPost· 4 days agoRiding a bike, whether indoor or outdoor, is great for knee health, according to a recent study....
Clinical trial leads to FDA approved treatment for peripheral artery disease
MinnPost· 3 days agoPeripheral artery disease or PAD, said Jennifer Jones-McMeans, Ph.D., divisional vice president of...
Insider Sale: Chief Scientific Officer & COO Pad Chivukula Sells
Guru Focus· 3 days agoFollowing this transaction, the insider now owns 447,448 shares of the company. Arcturus Therapeutics Holdings Inc is a biotechnology company focused on the development of novel RNA therapeutics ...
Avinger shifts focus to coronary disease, cuts peripheral staff By Investing.com
Investing.com· 2 days agoAvinger, Inc. (NASDAQ:AVGR), a medical device company, is refocusing its efforts on its coronary...
Are the PAD Interventions for Men Safe in Women?
Medscape· 2 days agoWomen are underrepresented in endovascular therapy trials. A new analysis of REVIVE data delves into the stent and bypass surgical outcomes for women.
Reviewers Say This Wearable Heating Pad Has Saved Them From All Kinds Of Pain
HuffPost· 2 days agoWhether you deal with gnarly menstrual cramps, stomachaches, back pains or other body aches, this...
Pad Chivukula Sells 26,000 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Stock
ETF DAILY NEWS· 2 days agoArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) COO Pad Chivukula sold 26,000 shares of the company’s stock in a transaction that occurred on Monday, June ...
PathMaker secures funding from US DoD for neuromodulation ALS trial
Medical Device Network via Yahoo Finance· 8 hours agoAlthough it’s not known exactly what drives motor neuron dysfunction in ALS, one process that is...
Three red flag signs in your feet could be warning of silent killer
Daily Express· 1 day agoHigh cholesterol is often a symptomless but potentially deadly condition, earning it the title of a...
Johnson & Johnson acquires Shockwave in $13.1bn deal
Medical Device Network via Yahoo Finance· 4 days agoShockwave specialises in coronary artery disease (CAD) and peripheral artery disease (PAD) treatments. Its core products are its intravascular ...